Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”

Sabine Ettinger,1 Michal Stanak,1 Piotr Szymański,2 Claudia Wild,1 Romana Tandara Haček,3 Darija Erčević,3 Renata Grenković,3 Gregor Goetz,1 Mirjana Huić3 1Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, Austria; 2Institute of Cardiology, Warsaw, Poland; 3Department for Developm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ettinger S, Stanak M, Szymański P, Wild C, Tandara Haček R, Erčević D, Grenković R, Goetz G, Huić M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
N/A
Acceso en línea:https://doaj.org/article/08bd05f192f546ea9d8e63aa5c2918ef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:08bd05f192f546ea9d8e63aa5c2918ef
record_format dspace
spelling oai:doaj.org-article:08bd05f192f546ea9d8e63aa5c2918ef2021-12-02T04:14:57ZReply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”1179-1470https://doaj.org/article/08bd05f192f546ea9d8e63aa5c2918ef2019-03-01T00:00:00Zhttps://www.dovepress.com/reply-to-comments-on-the-authors-reply-to-the-critical-appraisal-conce-peer-reviewed-article-MDERhttps://doaj.org/toc/1179-1470Sabine Ettinger,1 Michal Stanak,1 Piotr Szymański,2 Claudia Wild,1 Romana Tandara Haček,3 Darija Erčević,3 Renata Grenković,3 Gregor Goetz,1 Mirjana Huić3 1Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, Austria; 2Institute of Cardiology, Warsaw, Poland; 3Department for Development, Research, and Health Technology Assessment, Agency for Quality and Accreditation in Health Care and Social Welfare, Zagreb, CroatiaAlthough we clearly outlined our answers in our previous letter,1 we are pleased to clarify further any remaining open issues. There might be diverse views with regard to comparators of the wearable cardioverter defibrillator (WCD). We would like to refer the readers to our previous answer,1 where we explained our rationale for choosing the implantable cardioverter defibrillator as one of the comparators. It was selected based on broad indications stated in the CE mark and after discussions with clinicians. Furthermore, in this case, a change of the comparator, ie, the implantable cardioverter defibrillator, would not have led to a different result or conclusion.View the original paper by Ettinger and colleagues.Two previous letters have been published Sperzel et al Sperzel et alEttinger SStanak MSzymański PWild CTandara Haček RErčević DGrenković RGoetz GHuić MDove Medical PressarticleN/AMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol Volume 12, Pp 129-131 (2019)
institution DOAJ
collection DOAJ
language EN
topic N/A
Medical technology
R855-855.5
spellingShingle N/A
Medical technology
R855-855.5
Ettinger S
Stanak M
Szymański P
Wild C
Tandara Haček R
Erčević D
Grenković R
Goetz G
Huić M
Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
description Sabine Ettinger,1 Michal Stanak,1 Piotr Szymański,2 Claudia Wild,1 Romana Tandara Haček,3 Darija Erčević,3 Renata Grenković,3 Gregor Goetz,1 Mirjana Huić3 1Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, Austria; 2Institute of Cardiology, Warsaw, Poland; 3Department for Development, Research, and Health Technology Assessment, Agency for Quality and Accreditation in Health Care and Social Welfare, Zagreb, CroatiaAlthough we clearly outlined our answers in our previous letter,1 we are pleased to clarify further any remaining open issues. There might be diverse views with regard to comparators of the wearable cardioverter defibrillator (WCD). We would like to refer the readers to our previous answer,1 where we explained our rationale for choosing the implantable cardioverter defibrillator as one of the comparators. It was selected based on broad indications stated in the CE mark and after discussions with clinicians. Furthermore, in this case, a change of the comparator, ie, the implantable cardioverter defibrillator, would not have led to a different result or conclusion.View the original paper by Ettinger and colleagues.Two previous letters have been published Sperzel et al Sperzel et al
format article
author Ettinger S
Stanak M
Szymański P
Wild C
Tandara Haček R
Erčević D
Grenković R
Goetz G
Huić M
author_facet Ettinger S
Stanak M
Szymański P
Wild C
Tandara Haček R
Erčević D
Grenković R
Goetz G
Huić M
author_sort Ettinger S
title Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
title_short Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
title_full Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
title_fullStr Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
title_full_unstemmed Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
title_sort reply to: comments on the authors’ reply to the critical appraisal concerning “wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/08bd05f192f546ea9d8e63aa5c2918ef
work_keys_str_mv AT ettingers replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo
AT stanakm replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo
AT szymanskip replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo
AT wildc replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo
AT tandarahacekr replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo
AT ercevicd replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo
AT grenkovicr replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo
AT goetzg replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo
AT huicm replytocommentsontheauthorsrsquoreplytothecriticalappraisalconcerningldquowearablecardioverterdefibrillatorsforthepreventionofsuddencardiacarrestahealthtechnologyassessmentandpatientfocusgroupstudyrdquo
_version_ 1718401349541953536